A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib Malate or SHR-1701 for Neoadjuvant Therapy in Patients With Advanced Ovarian Cancer
Clinical trial NCT07355010 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07355010
- Sponsor
- Qinglei Gao
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-12-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.